Impact of Process Parameters and Formulation Properties on Dissolution Performance of an Extended Release Tablet: a Multivariate Analysis

2021 ◽  
Author(s):  
Samir Diab ◽  
Gabriele Bano ◽  
Ranjit M. Dhenge ◽  
James Taylor
Keyword(s):  
Multivariate Analysis ◽  
Process Parameters ◽  
Extended Release ◽  
Extended Release Tablet ◽  
Release Tablet

Dose Proportionality of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology

2015 ◽  
Vol 35 (5) ◽  
pp. 291-297 ◽  
Author(s):  
Mona Darwish ◽  
Ronghua Yang ◽  
William Tracewell ◽  
Philmore Robertson ◽  
Mary Bond
Keyword(s):  
Extended Release ◽  
Dose Proportionality ◽  
Extended Release Tablet ◽  
Release Tablet

scholarly journals Evaluation of the Relative Intranasal Abuse Potential of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users

Pain Medicine ◽  
2017 ◽  
Vol 19 (8) ◽  
pp. 1597-1612
Author(s):  
Mary Bond ◽  
Kerri A Schoedel ◽  
Laura Rabinovich-Guilatt ◽  
Maciej Gasior ◽  
William Tracewell ◽  
...  
Keyword(s):  
Extended Release ◽  
Abuse Potential ◽  
Opioid Users ◽  
Extended Release Tablet ◽  
Release Tablet

Development of a Level A in Vitro-in Vivo Correlation for Veliparib (ABT-888) Extended Release Tablet Formulation

2017 ◽  
Vol 34 (6) ◽  
pp. 1187-1192 ◽  
Author(s):  
Rajendar K. Mittapalli ◽  
Silpa Nuthalapati ◽  
Alyssa E. Delke DeBord ◽  
Hao Xiong
Keyword(s):  
Extended Release ◽  
Tablet Formulation ◽  
Extended Release Tablet ◽  
Release Tablet

Novel solid forms of oxaprozin: cocrystals and an extended release drug–drug salt of salbutamol

RSC Advances ◽  
2016 ◽  
Vol 6 (41) ◽  
pp. 34110-34119 ◽  
Author(s):  
Srinivasulu Aitipamula ◽  
Annie B. H. Wong ◽  
Pui Shan Chow ◽  
Reginald B. H. Tan
Keyword(s):  
Extended Release ◽  
Inflammatory Drug ◽  
Release Drug ◽  
Tablet Formulations ◽  
Anti Inflammatory ◽  
Extended Release Tablet ◽  
Release Tablet

Novel solid forms of an anti-inflammatory drug, oxaprozin, were identified. A drug–drug salt of oxaprozin with salbutamol was proved promising for development of extended release tablet formulations of salbutamol.

Sign in / Sign up

Export Citation Format

Share Document